Source link : https://newshealth.biz/health-news/adding-tucatinib-in-first-line-delays-progression-in-mets-bc/
Overall, tucatinib add-on to first-line maintenance therapy for HER2-positive metastatic breast cancer delayed progression by 8.6 months. Medscape Medical News Source link : https://www.medscape.com/viewarticle/adding-tucatinib-first-line-delays-progression-metastatic-2025a1000ywu?src=rss Author : Publish date : 2025-12-12 11:09:00 Copyright for syndicated content belongs to the linked Source.
The post Adding Tucatinib in First-Line Delays Progression in Mets BC first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-12 11:09:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8